The week's investing action plan includes a strong dose of pharma and biotech earnings, January econ reports, plus Amazon and Alphabet.

A comprehensive marketing/launch plan for a phase III drug will be developed. Lectures will be supplemented by guest speakers and case studies. In the pharmaceutical market, sales and share growth are ...